点阵剥脱激光治疗增生性瘢痕前后患者报告的疼痛与瘙痒水平
本研究回顾性分析点阵剥脱激光治疗症状性增生性瘢痕(HTS)的疼痛与瘙痒反应差异。110例疼痛、137例瘙痒患者中,多数为无应答者(疼痛56.4%、瘙痒55.1%);应答者首次治疗后疼痛和瘙痒显著下降并保持稳定(P<.0001),无应答者疼痛无改善、瘙痒首次治疗后显著加重。人口学与损伤特征不能预测治疗反应。
要点
- 点阵剥脱激光治疗HTS后多数患者疼痛和瘙痒无应答。
- 应答者首次治疗后症状显著改善并稳定(P<.0001)。
- 基线疼痛和瘙痒评分较高者更可能应答。
核心结论
- 点阵剥脱激光治疗症状性增生性瘢痕后,多数患者疼痛和瘙痒未达应答标准。
- 应答者首次治疗后疼痛和瘙痒显著降低并维持稳定(P<.0001)。
研究设计与样本
- 回顾性病历分析,评估点阵剥脱激光治疗症状性增生性瘢痕的疼痛和瘙痒反应。
- 疼痛分析110例,瘙痒分析137例,使用患者瘢痕评估量表(1=低,10=高)于治疗前及6次激光治疗后评估。
主要发现
- 疼痛无应答者占56.4%,瘙痒无应答者占55.1%。
- 应答者首次治疗后疼痛和瘙痒显著下降,此后评分稳定(P<.0001)。
- 无应答者疼痛无显著改善,瘙痒首次治疗后显著加重。
- 应答者基线疼痛和瘙痒评分高于无应答者。
- 性别、皮肤类型、种族、瘢痕年龄、瘢痕大小或患者年龄组间无显著差异。
关键数值与推荐
- 疼痛应答定义为改善≥3分(n=48),无应答为改善≤2分或加重(n=62)。
- 瘙痒应答定义为改善≥3分(n=62),无应答为改善≤2分或加重(n=76)。
临床怎么用
- 治疗前应告知患者多数可能疼痛和瘙痒无应答。
- 基线症状较重者更可能从点阵剥脱激光中获益。
- 症状改善主要出现在首次治疗后,后续治疗维持稳定。
局限性
- 回顾性设计。
- 未报告人口学或损伤特征对治疗反应的预测价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Skin fibrosis, especially hypertrophic scars (HTSs), remains understudied with few effective treatments. Studying HTS is challenging due to its natural tendency to improve over time, making it hard to separate intervention effects. This study evaluated fractional ablative laser treatment for symptomatic HTSs, focusing on variability in patient response. It was hypothesized that pain and itch would decrease posttreatment, and that demographic or injury characteristics might predict responders. A retrospective chart review analyzed pretreatment and 6 postlaser sessions using the Patient Scar Assessment Scale for pain and itch (1 = low, 10 = high). Patients showing a ≥ 3 point improvement were classified as "responders" (n = 48 for pain, n = 62 for itch); those with ≤ 2 point improvement or worsening were "nonresponders" (n = 62 for pain, n = 76 for itch). In total, 110 patients were analyzed for pain and 137 for itch. Most patients were nonresponders for both pain (56.4%) and itch (55.1%). Responders experienced significant reductions in pain and itch after the first session, with stable scores thereafter (P < .0001). Nonresponders showed no significant improvement in pain and, for itch, even a significant worsening after the first session. No significant differences were found between groups based on sex, skin type, race, scar age, scar size, or patient age. Responders had higher baseline pain and itch scores than nonresponders. The greatest symptom relief occurred after the first treatment. Demographic and injury characteristics did not predict treatment response.
引用
- Carreras JP, Carney BC, Lee D, et al. Patient-Reported Levels of Pain and Itch in Hypertrophic Scar Before and After Fractional Ablative Laser Treatment. J Burn Care Res. 2026. PMID: 41649169. doi:10.1093/jbcr/irag012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。